Eli Lilly
-
GLP-1 pill vs injection: How do they compare for Canadians?As a new oral weight loss drug is on the horizon for Canadians, how does the pill compare to injectable GLP-1 drugs? We asked the experts.HealthNov 19
-
GLP-1 drugs are driving higher sales for Eli Lilly and Novo NordiskSales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.HealthAug 5
-
-
Advertisement
-
‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’sThis is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved lecanemab, commercially known as Leqembi, in October 2025.CanadaMay 4
-
-
Advertisement
-
FDA approves new Alzheimer’s drug that slows memory declineA key differentiating factor for donanemab is the drug's finite dosing, which allows patients to stop taking the treatment once brain scans no longer show amyloid plaques.HealthJul 3, 2024
-
Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDAThe U.S. Food and Drug Administration has delayed its decision on Eli Lilly's LLY.N experimental treatment for early Alzheimer's disease.HealthMar 8, 2024
-
-
Eli Lilly’s new version of diabetes drug Mounjaro approved for weight loss by FDAA new version of the popular diabetes treatment Mounjaro from Eli Lilly can be sold as a weight-loss drug, U.S. regulators announced Wednesday.HealthNov 8, 2023
-
-
Alzheimer’s drug slows progression in patients. It may soon be approved in U.S.Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.HealthJul 17, 2023
-
No insulin price cut coming for Canada despite U.S. slashes, Eli Lilly saysEli Lilly and Co. announced Wednesday that it will cut prices for some of its most commonly prescribed insulin products in the United States.CanadaMar 3, 2023
-
-
Advertisement
-
Drugmaker Eli Lilly slashes prices, will offer $35 insulin in U.S. pharmaciesIn addition to slashing some drug prices by 70 per cent, Eli Lilly also promised to expand an existing program that caps some insulin products at $50.U.S. NewsMar 1, 2023
-
-
Advertisement
-
FDA authorizes new antibody drug that targets Omicron COVID-19 variantThe Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19.WorldFeb 11, 2022
Trending
-
-
‘Multiple trade issues’ outstanding in Canada, U.S. trade talks: Sources
16,249 READ -
Ontario fugitive arrested in Winnipeg hours after making most wanted list
13,026 READ -
Secularism to pass Christianity as main group in Canada by 2050: Pew
11,344 READ -
Fiona the hippo dead days after ingesting knitted hat, zoo says
9,938 READ
Top Videos
-
Hostage standoff in Airdrie, stolen loader pursuit amongst recent serious RCMP calls139 Viewed -
Potential mega-merger: Why Quebecor wants to buy Telus for $31B132 Viewed -
‘They’ve never treated us fairly’: Trump slams Canada after meeting with Carney115 Viewed -
Health Matters: Health Canada approves new GLP-1 pill82 Viewed -
Knife-wielding man holds 13-year-old girl hostage in Russia73 Viewed -
New York City targets 2032 for Rikers Island jail closure73 Viewed -
Global National: Nov. 1971 Viewed -
Anthropic slides about 9% on its second day of trading amid market sell-off64 Viewed -
Dozens arrested, 3 in Canada amid RCMP, FBI crime crackdown55 Viewed -
Rubio says there’s ‘no evidence’ that major U.S. tech outages are connected51 Viewed -